The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls

被引:39
作者
Glasgow, JFT
Middleton, B [1 ]
Moore, R
Gray, A
Hill, J
机构
[1] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England
[2] Queens Univ Belfast, Royal Belfast Hosp Sick Children, Nuffield Dept Child Hlth, Belfast BT12 6BA, Antrim, North Ireland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1999年 / 1454卷 / 01期
关键词
Reye's syndrome; salicylate; hydroxyhippurate; gentisate; fatty acid beta-oxidation; 3-hydroxyacyl-CoA dehydrogenase; mitochondrial trifunctional enzyme;
D O I
10.1016/S0925-4439(99)00025-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of aspirin metabolites on beta-oxidation were studied in skin fibroblasts from eight typical Reye's syndrome (RS) patients and controls. RS patients' cells did not differ from controls in rates of palmitate oxidation or in the three component activities of the mitochondrial trifunctional enzyme (MTE), indicating no inherited beta-oxidation defect. Aspirin metabolites salicylate, hydroxyhippurate and gentisate, but not aspirin, directly inhibited palmitate oxidation in control and RS cells. RS cells were significantly more sensitive to inhibition than controls at 0.5 to 5 mM salicylate. Inhibition was concentration-dependent and reversible. Inhibition did not occur in fibroblasts lacking activity of the long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) activity of MTE. Salicylate was therefore inhibiting beta-oxidation at this step. Hydroxyhippurate and salicylate reversibly inhibited HAD activities in extracts of control and RS cells. Studies with pure short-chain HAD and LCHAD (MTE) showed hydroxyhippurate and salicylate were competitive inhibitors of the former but mixed (not competitive) inhibitors of the latter. Both compounds inhibited the combined, three-step, MTE reaction measured in the physiological direction. We conclude that (1) salicylate and hydroxyhippurate decrease beta-oxidation in intact cells by reversible inhibition of LCHAD activity of the MTE, and (2) beta-oxidation in RS cells is inherently more sensitive to inhibition by low concentrations of salicylate than controls. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文
共 44 条
[1]  
ARROWSMITH JB, 1987, PEDIATRICS, V79, P858
[2]  
BALDWIN GS, 1996, FEBS LETT, V384, P56
[3]   FACTORS CONTROLLING RATE OF FATTY-ACID BETA-OXIDATION IN RAT-LIVER MITOCHONDRIA [J].
BREMER, J ;
WOJTCZAK, AB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 280 (04) :515-530
[4]  
BRODY TM, 1956, J PHARMACOL EXP THER, V117, P39
[5]   HUMAN LIVER LONG-CHAIN 3-HYDROXYACYL-COENZYME-A DEHYDROGENASE IS A MULTIFUNCTIONAL MEMBRANE-BOUND BETA-OXIDATION ENZYME OF MITOCHONDRIA [J].
CARPENTER, K ;
POLLITT, RJ ;
MIDDLETON, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (02) :443-448
[6]   NEW DEVELOPMENTS IN THE DIAGNOSIS AND INVESTIGATION OF MITOCHONDRIAL FATTY-ACID OXIDATION DISORDERS [J].
COATES, PM .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (07) :S49-S56
[7]   RELATIONSHIP BETWEEN UNUSUAL HEPATIC ACYL COENZYME-A PROFILES AND THE PATHOGENESIS OF REYE SYNDROME [J].
CORKEY, BE ;
HALE, DE ;
GLENNON, MC ;
KELLEY, RI ;
COATES, PM ;
KILPATRICK, L ;
STANLEY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) :782-788
[8]  
DESCHAMPS D, 1991, J PHARMACOL EXP THER, V259, P894
[9]   Control of mitochondrial β-oxidation:: sensitivity of the trifunctional protein to [NAD+]/[NADH] and [acetyl-CoA]/[CoA] [J].
Eaton, S ;
Middleton, B ;
Bartlett, K .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1998, 1429 (01) :230-238
[10]   NEW EPIDEMIOLOGIC EVIDENCE CONFIRMING THAT BIAS DOES NOT EXPLAIN THE ASPIRIN REYES-SYNDROME ASSOCIATION [J].
FORSYTH, BW ;
HORWITZ, RI ;
ACAMPORA, D ;
SHAPIRO, ED ;
VISCOLI, CM ;
FEINSTEIN, AR ;
HENNER, R ;
HOLABIRD, NB ;
JONES, BA ;
KARABELAS, ADE ;
KRAMER, MS ;
MICLETTE, M ;
WELLS, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (17) :2517-2524